Related Experiment Video
Updated: Feb 13, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Antibody-Based Agents in the Management of Antibiotic-Resistant Staphylococcus aureus Diseases
Pietro Speziale1,2, Simonetta Rindi3, Giampiero Pietrocola4
1Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy. pspeziale@unipv.it.
Abstract:
Staphylococcus aureus is a human pathogen that can cause a wide spectrum of diseases, including sepsis, pneumonia, arthritis, and endocarditis. Ineffective treatment of a number of staphylococcal infections with antibiotics is due to the development and spread of antibiotic-resistant strains following decades of antibiotic usage. This has generated renewed interest within the scientific community in alternative therapeutic agents, such as anti-S. aureus antibodies. Although the role of antibodies in the management of S. aureus diseases is controversial, the success of this pathogen in neutralizing humoral immunity clearly indicates that antibodies offer the host extensive protection. In this review, we report an update on efforts to develop antibody-based agents, particularly monoclonal antibodies, and their therapeutic potential in the passive immunization approach to the treatment and prevention of S. aureus infections.
Insights
Antibiotic-resistant Staphylococcus aureus infections necessitate new treatments. This review explores antibody-based therapies, including monoclonal antibodies, for passive immunization against S. aureus.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Staphylococcus aureus is a significant human pathogen causing diverse infections.
- Antibiotic resistance in S. aureus strains limits treatment options.
- Alternative therapies are needed due to widespread antibiotic resistance.
Purpose of the Study:
- To review the development of antibody-based agents against S. aureus.
- To assess the therapeutic potential of monoclonal antibodies for passive immunization.
- To update on strategies for treating and preventing S. aureus infections.
Main Methods:
- Literature review of current research on anti-S. aureus antibodies.
- Analysis of studies on monoclonal antibody development for S. aureus.
- Evaluation of passive immunization strategies.
Main Results:
- Antibody-based therapies are a promising alternative to antibiotics.
- Monoclonal antibodies show potential for targeted treatment and prevention.
- Despite controversy, antibodies offer significant host protection against S. aureus.
Conclusions:
- Antibody-based agents, particularly monoclonal antibodies, represent a viable therapeutic avenue.
- Passive immunization with antibodies can aid in managing S. aureus infections.
- Further development is crucial for effective antibody-based treatments against resistant strains.
Related Concept Videos
Development of Antibiotic Resistance
Antibiotic Selection
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Rheumatic Heart Disease III: Medical Management

